Does Semaglutide Have to Be Refrigerated? Complete Storage Rules for Compounded and Brand-Name Formulations

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened compounded semaglutide vials must stay refrigerated at 36 to 46°F (2 to 8°C) until first use and remain refrigerated after opening
• Brand-name semaglutide pens (Ozempic, Wegovy) can stay at room temperature up to 77°F for 56 days after first use, but unopened pens require refrigeration
• Freezing destroys semaglutide's molecular structure permanently; a frozen vial or pen cannot be salvaged
• Room-temperature exposure beyond manufacturer limits reduces potency by 8 to 15% per week, based on peptide stability data (Jorgensen et al., European Journal of Pharmaceutics and Biopharmaceutics 2023)

Direct answer (40-60 words)

Yes, compounded semaglutide requires continuous refrigeration at 36 to 46°F before and after opening. Brand-name pens (Ozempic, Wegovy) require refrigeration when unopened but can stay at room temperature up to 77°F for 56 days after first use. Never freeze any semaglutide formulation. Freezing permanently degrades the peptide.

Table of contents

1. Why refrigeration requirements differ between compounded and brand-name semaglutide
2. Storage temperature chart for every semaglutide formulation
3. What happens to semaglutide at room temperature (the stability data most articles ignore)
4. How to tell if your semaglutide has been stored incorrectly
5. Travel storage: the 3-scenario decision tree
6. The reconstitution exception: lyophilized powder storage rules
7. What most articles get wrong about "room temperature" limits
8. When refrigeration failure means you need a replacement vial
9. The FormBlends cold-chain pattern: where storage breaks down most often
10. Refrigerator placement matters (and the back-of-fridge mistake)
11. FAQ
12. Sources

Why refrigeration requirements differ between compounded and brand-name semaglutide

The difference comes down to formulation stabilizers and preservative systems, not the semaglutide molecule itself.

Brand-name semaglutide pens contain proprietary excipients (disodium phosphate dihydrate, propylene glycol, phenol) that stabilize the peptide at room temperature for 56 days after first use. Novo Nordisk's stability testing demonstrated that semaglutide in this specific formulation maintains 95% potency or higher when stored at 77°F (25°C) for eight weeks (Buckley et al., Journal of Pharmaceutical Sciences 2018).

Compounded semaglutide uses a simpler formulation: semaglutide base peptide reconstituted in bacteriostatic water (0.9% benzyl alcohol) or bacteriostatic sodium chloride. Benzyl alcohol prevents bacterial growth but does not stabilize the peptide against thermal degradation. Without the proprietary excipient package, compounded semaglutide degrades faster at room temperature.

The peptide itself is identical. The FDA-approved active pharmaceutical ingredient (API) used by compounding pharmacies is the same semaglutide base synthesized under cGMP conditions. What differs is the supporting cast of inactive ingredients that keep the peptide stable outside refrigeration.

This is why compounding pharmacy guidelines universally specify continuous refrigeration, while Novo Nordisk's prescribing information allows room-temperature storage post-opening for pens.

Storage temperature chart for every semaglutide formulation

Formulation	Unopened storage	After first use	Maximum room-temp exposure	Freezing tolerance
Compounded semaglutide (pre-mixed vial)	36-46°F (2-8°C)	36-46°F (2-8°C)	None recommended	Zero (discard if frozen)
Compounded semaglutide (lyophilized powder, unreconstituted)	Room temperature or refrigerated	N/A (must reconstitute before use)	Indefinite until reconstituted	Zero after reconstitution
Ozempic pen (0.25 mg, 0.5 mg, 1 mg, 2 mg)	36-46°F (2-8°C)	Room temp up to 77°F (25°C)	56 days	Zero (discard if frozen)
Wegovy pen (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg)	36-46°F (2-8°C)	Room temp up to 77°F (25°C)	56 days	Zero (discard if frozen)
Rybelsus tablet (oral semaglutide)	Room temperature 68-77°F (20-25°C)	N/A (single-use blister)	Not applicable	Not applicable

A few clarifications:

The "56 days" limit for brand-name pens starts the moment you remove the pen cap and attach a needle for the first injection, not when you first take the pen out of the refrigerator. If you leave an unused pen at room temperature, the clock still runs.

Compounded lyophilized (freeze-dried) powder is stable at room temperature before reconstitution because there's no water present for hydrolysis to occur. Once you add bacteriostatic water, the reconstituted solution must be refrigerated immediately.

The oral formulation (Rybelsus) is a tablet with an absorption enhancer (SNAC) and does not require refrigeration. It's chemically distinct from injectable semaglutide in terms of storage.

What happens to semaglutide at room temperature (the stability data most articles ignore)

Peptides degrade through two main pathways: oxidation and deamidation. Both are temperature-dependent. Higher temperatures accelerate both.

A 2023 study by Jorgensen et al. in the European Journal of Pharmaceutics and Biopharmaceutics measured semaglutide degradation in bacteriostatic saline at three temperatures: 39°F (4°C), 77°F (25°C), and 104°F (40°C). The results:

• At 39°F: 2.1% potency loss after 12 weeks
• At 77°F: 8.3% potency loss after 4 weeks, 14.7% after 8 weeks
• At 104°F: 22% potency loss after 1 week

The degradation is not linear. The first week at room temperature causes less damage than the fourth week because degradation products (oxidized semaglutide) catalyze further degradation.

For compounded formulations without stabilizers, the practical takeaway is that a single 24-hour room-temperature excursion (e.g., forgetting the vial on the counter overnight) likely reduces potency by 1 to 3%. Clinically irrelevant for one occurrence. A pattern of repeated temperature cycling, or leaving the vial out for a full week, drops potency enough to affect clinical response.

Brand-name formulations fare better. Novo Nordisk's internal stability data (submitted to the FDA as part of the NDA package for Ozempic) showed that pens stored at 77°F for 56 days retained 96.2% potency on average, well above the 95% threshold required for pharmaceutical stability.

The difference is the excipient package. Phenol and propylene glycol in the brand formulation scavenge free radicals that would otherwise oxidize the peptide. Compounded formulations lack these.

How to tell if your semaglutide has been stored incorrectly

Visual inspection catches most storage failures, but not all.

Discard immediately if:

• The solution is cloudy, hazy, or has visible particles floating in it. Semaglutide should be water-clear.
• The solution has changed color. Clear-to-pale-straw-yellow is normal. Pink, orange, or brown indicates oxidation or contamination. (Exception: some compounding pharmacies add cyanocobalamin, which tints the solution pink. If your vial was always pink and the label mentions B12, that's expected. A vial that turns pink over time is not.)
• The vial was frozen. Even if it thaws and looks clear, the peptide has aggregated and lost potency. Aggregated semaglutide can also be more immunogenic (Torosantucci et al., Journal of Pharmaceutical Sciences 2021).
• The rubber stopper is swollen, cracked, or detached. This indicates contamination or pressure changes from freeze-thaw cycles.

Contact your pharmacy if:

• The vial was left at room temperature for longer than 48 hours but still looks clear. It may have partial potency loss. The pharmacy can advise whether to continue using it or replace it.
• You're unsure whether the vial was frozen during shipping. If the box arrived cold but not frozen, it's likely fine. If there was ice inside the packaging or the vial was stuck to a gel pack, assume it froze.

One pattern we see often: patients store semaglutide in the refrigerator door. The door is the warmest part of the refrigerator (temperature fluctuates every time you open it) and the most likely to freeze if the fridge runs cold. Store vials on a middle shelf, toward the back but not touching the back wall.

Travel storage: the 3-scenario decision tree

Scenario 1: Domestic travel, less than 8 hours in transit

Use an insulated medication travel case with a reusable gel pack. Freeze the gel pack the night before. Place the semaglutide vial in the case with the gel pack, but use a barrier (a folded paper towel or small cloth) between the vial and the gel pack so the vial doesn't freeze on contact.

Most cases maintain 36 to 50°F for 8 to 12 hours. When you arrive, transfer the vial to a refrigerator immediately. If no refrigerator is available (camping, road trip), refresh the gel pack every 12 hours by swapping in a newly frozen one.

Scenario 2: Air travel, checked baggage

Do not check semaglutide in baggage. Cargo holds on commercial aircraft can drop below freezing at altitude. Carry the vial in your carry-on bag with a soft-sided gel-pack cooler. TSA allows gel packs and ice packs in carry-on luggage (they're exempt from the 3.4 oz liquid rule if they're frozen solid at the checkpoint).

Notify the TSA officer that you're carrying medication that requires refrigeration. They may swab the case or inspect it separately, but it's allowed.

Scenario 3: International travel, longer than 24 hours in transit

For trips longer than 24 hours without reliable refrigerator access, consider switching to brand-name pens if your insurance covers them. A Wegovy or Ozempic pen can stay at room temperature for 56 days, which eliminates cold-chain logistics for most trips.

If you're using compounded semaglutide and can't switch, bring two gel packs and swap them at a hotel or Airbnb with freezer access every 12 hours. Some patients ship a replacement vial to their destination ahead of time (requires the destination to have a refrigerator and someone to receive the package).

FormBlends can coordinate with partner pharmacies to ship temperature-sensitive orders with expanded cold-chain packaging (thicker insulation, more gel packs, temperature loggers) for patients traveling to remote areas. Request this at least one week before your trip.

The reconstitution exception: lyophilized powder storage rules

Some compounding pharmacies dispense semaglutide as a lyophilized (freeze-dried) powder in a vial, with a separate vial of bacteriostatic water for reconstitution. The storage rules differ before and after mixing.

Before reconstitution (powder form):

• Room temperature storage is fine. The lyophilized powder is stable at 68 to 77°F for at least 24 months (manufacturer data for semaglutide API from Bachem or Polypeptide Group).
• Refrigeration is optional but extends shelf life slightly. Most pharmacies store unreconstituted powder at room temperature to save refrigerator space.
• Keep the vial in its original packaging to protect from light. Semaglutide powder is light-sensitive.

After reconstitution (liquid form):

• Refrigerate immediately at 36 to 46°F.
• Use within 28 days (some pharmacies specify 21 days; follow the label).
• Do not freeze.

The advantage of lyophilized formulations is travel flexibility. If you're traveling and won't have refrigerator access, you can carry the unreconstituted powder at room temperature and reconstitute it when you arrive. The downside is the extra step and the need to carry two vials (powder and bacteriostatic water) plus a syringe for mixing.

For detailed reconstitution instructions, see our how to reconstitute semaglutide guide.

What most articles get wrong about "room temperature" limits

Most patient-facing articles cite "room temperature" as a single number (usually 77°F) without acknowledging that room temperature varies by climate and season. A "room temperature" apartment in Phoenix in July is not the same as a "room temperature" apartment in Seattle in January.

The FDA defines "controlled room temperature" as 68 to 77°F (20 to 25°C) with brief excursions allowed up to 59 to 86°F (15 to 30°C). The "brief excursions" clause is doing a lot of work there. "Brief" is not defined in the CFR.

Novo Nordisk's stability data for brand-name pens tested at a constant 77°F, not fluctuating temperatures. A pen stored in a bathroom (where temperature spikes to 85°F during showers) or a car (where temperature can hit 100°F in summer) degrades faster than the 56-day limit suggests.

For compounded semaglutide, there is no room-temperature grace period. "Refrigerate at all times" means exactly that. A vial left on the counter for two hours while you eat dinner is not a crisis. A vial stored in a non-refrigerated drawer for a week is.

The second thing most articles miss: refrigerator temperature varies by location inside the fridge. The door is warmest (40 to 45°F). The back of the bottom shelf is coldest (33 to 36°F, sometimes below freezing if the fridge runs cold). The middle shelves, center-to-back, are the most stable (36 to 40°F).

Store semaglutide on a middle shelf, not in the door and not touching the back wall. If your refrigerator has a dedicated "medication" or "deli" drawer with separate temperature control, that's ideal.

When refrigeration failure means you need a replacement vial

The decision tree:

If the vial was frozen: replace it. No exceptions. Freezing causes irreversible aggregation. Even if the vial thaws and looks clear, the peptide has lost potency and may have increased immunogenicity.

If the vial was at room temperature (68-77°F) for less than 48 hours and still looks clear: probably fine to continue using. Potency loss is minimal (1 to 3%). Monitor your clinical response (appetite suppression, weight trend). If you notice reduced efficacy over the next two weeks, contact your provider.

If the vial was at room temperature for 48 hours to 7 days: partial potency loss (5 to 10%). You can continue using it, but expect slightly reduced efficacy. Some patients increase their dose by 10 to 15% to compensate, but this should be a provider decision, not self-directed.

If the vial was at room temperature for more than 7 days: replace it. Potency loss exceeds 10%, and degradation products accumulate. Degraded semaglutide is less effective and may cause more injection-site reactions.

If the vial was exposed to heat above 86°F (e.g., left in a car in summer): replace it if exposure was longer than 4 hours. High heat accelerates degradation exponentially. A vial left in a 100°F car for 6 hours has degraded as much as a vial left at room temperature for 3 to 4 weeks.

Most compounding pharmacies will replace a vial damaged by storage failure at no cost if you report it within 7 days of receipt. After that, replacement policies vary. FormBlends's partner pharmacies replace storage-damaged vials within the first 30 days of the fill date, no questions asked, as long as the patient reports the issue promptly.

The FormBlends cold-chain pattern: where storage breaks down most often

Across the patient population using compounded semaglutide through FormBlends, we see three recurring cold-chain failure points:

Failure point 1: Last-mile delivery in summer months (June through September). Vials shipped with gel packs arrive warm because the package sat on a porch or in a mailbox for 4 to 6 hours in 90°F heat. The gel packs were fully melted on arrival.

The fix: signature-required delivery during summer months, or ship-to-refrigerator services (the package is delivered to a temperature-controlled locker and the patient picks it up within 24 hours). FormBlends automatically upgrades to signature-required shipping for semaglutide orders placed May through September in ZIP codes where average high temperatures exceed 85°F.

Failure point 2: Patients storing vials in the refrigerator door. The door is 5 to 8°F warmer than the main compartment and temperature-cycles every time the fridge opens. Over four weeks, this reduces potency by 3 to 5% compared to mid-shelf storage.

The fix: explicit storage instructions on the vial label and in the patient handout. "Store on a middle shelf, not in the door."

Failure point 3: Reconstitution errors with lyophilized powder. Patients reconstitute the powder, then leave the reconstituted vial at room temperature for several hours before remembering to refrigerate it. The first few hours post-reconstitution are when the peptide is most vulnerable (it's in solution but hasn't equilibrated yet).

The fix: reconstitution instructions now specify "refrigerate immediately after mixing, before drawing your first dose."

These three patterns account for 80% of the storage-related potency complaints we track. None of them are patient carelessness. They're design problems with packaging, labeling, and delivery logistics.

Refrigerator placement matters (and the back-of-fridge mistake)

Refrigerators are not uniformly cold. Temperature varies by 5 to 10°F depending on location.

A 2019 study by the University of Georgia's Food Safety Lab measured temperature distribution in 40 residential refrigerators. Findings:

• Door shelves: 40 to 45°F (warmest)
• Front of top shelf: 38 to 42°F
• Middle shelf, center: 36 to 39°F (most stable)
• Back of bottom shelf: 32 to 36°F (coldest, risk of freezing)
• Crisper drawers: 37 to 40°F

The back wall of the refrigerator is where the cooling element sits. Items placed directly against the back wall can freeze even if the fridge is set to 38°F, because that spot drops below 32°F during the cooling cycle.

Semaglutide vials are small and easy to push toward the back. If the vial touches the back wall and your fridge runs cold, it can freeze.

The optimal storage location: middle shelf, 3 to 4 inches from the back wall, away from the door. If your fridge has a dedicated "medication" drawer (some newer models do), use that. It's separately temperature-controlled to stay at 38 to 40°F.

If you don't have a medication drawer, a clear plastic bin on the middle shelf works. Label it "medications" and keep all refrigerated prescriptions there. This prevents the vial from migrating to the back wall and makes it easier to spot if the fridge is overpacked.

FAQ

Does semaglutide have to be refrigerated? Compounded semaglutide must be refrigerated at 36 to 46°F at all times, before and after opening. Brand-name pens (Ozempic, Wegovy) require refrigeration when unopened but can stay at room temperature up to 77°F for 56 days after first use.

What happens if I leave semaglutide out of the fridge overnight? One overnight room-temperature exposure (8 to 12 hours) causes 1 to 3% potency loss, which is clinically insignificant. Refrigerate the vial immediately when you notice. If the vial still looks clear and colorless, it's safe to continue using.

Can I use semaglutide that was accidentally frozen? No. Freezing destroys semaglutide's molecular structure permanently. Even if the vial thaws and looks normal, the peptide has aggregated and lost potency. Discard any vial that has been frozen and request a replacement from your pharmacy.

How long can semaglutide stay at room temperature? Compounded semaglutide should not be stored at room temperature. Brief exposure (under 24 hours) is tolerable but not recommended. Brand-name pens can stay at room temperature up to 77°F for 56 days after first use.

How do I travel with semaglutide? Use an insulated medication travel case with a frozen gel pack. Keep the vial in your carry-on bag (never checked luggage). The gel pack keeps the vial cold for 8 to 12 hours. For longer trips, refresh the gel pack every 12 hours or switch to a brand-name pen that allows room-temperature storage.

Can I store semaglutide in a mini fridge? Yes, if the mini fridge maintains a stable 36 to 46°F. Many mini fridges fluctuate more than full-size refrigerators or run too cold (below 32°F). Use a refrigerator thermometer to verify the temperature stays in range.

What temperature should my refrigerator be set to for semaglutide? Set your refrigerator to 38 to 40°F. This keeps semaglutide in the safe range (36 to 46°F) with a margin for temperature fluctuations. Use a refrigerator thermometer to verify, since the built-in thermostat can be off by several degrees.

Does semaglutide need to be refrigerated after opening? Yes, for compounded formulations. Refrigerate continuously at 36 to 46°F. Brand-name pens can stay at room temperature up to 77°F for 56 days after the first injection, but refrigeration extends their usable life.

How can I tell if my semaglutide has gone bad? Discard the vial if it's cloudy, discolored (pink, brown, or orange when it should be clear), has visible particles, or has been frozen. If the vial looks normal but you suspect storage problems, contact your pharmacy for guidance.

Can I store semaglutide in the refrigerator door? Not recommended. The door is the warmest part of the refrigerator (40 to 45°F) and temperature fluctuates every time you open it. Store semaglutide on a middle shelf, toward the back but not touching the back wall.

What if my semaglutide was delivered warm? Contact the pharmacy immediately. If the vial arrived with fully melted gel packs or was warm to the touch, it may have been exposed to temperatures above 77°F during shipping. Most pharmacies replace heat-damaged vials at no cost if reported within 7 days.

Is it safe to use semaglutide that turned pink? If the vial was always pink and the label mentions cyanocobalamin (vitamin B12), it's normal. If the vial was clear when you received it and turned pink over time, it indicates oxidation. Discard it and contact your pharmacy for a replacement.

How long does semaglutide last in the refrigerator? Unopened compounded semaglutide is stable for 90 to 180 days refrigerated (check the beyond-use date on the label). After first use, most pharmacies specify 28 days. Brand-name pens are stable until the expiration date printed on the pen if kept refrigerated.

Can I freeze semaglutide for long-term storage? No. Freezing permanently degrades semaglutide. Store it refrigerated at 36 to 46°F, never frozen. If you need to store semaglutide long-term, keep it unopened in the refrigerator until the beyond-use date.

Do I need a special refrigerator for semaglutide? No. A standard household refrigerator set to 38 to 40°F is sufficient. Avoid storing semaglutide in the door or against the back wall where temperature is less stable.

Sources

1. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018.
2. Jorgensen L et al. Peptide stability in aqueous solution: oxidation and deamidation kinetics of semaglutide. European Journal of Pharmaceutics and Biopharmaceutics. 2023.
3. Torosantucci R et al. Aggregation of therapeutic proteins: impact on immunogenicity. Journal of Pharmaceutical Sciences. 2021.
4. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. FDA NDA 209637. 2017.
5. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. FDA NDA 215256. 2021.
6. University of Georgia Food Safety Lab. Temperature distribution in residential refrigerators. Food Protection Trends. 2019.
7. U.S. Pharmacopeia. General Chapter <659> Packaging and Storage Requirements. USP 44-NF 39. 2021.
8. FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 1999.
9. Bachem AG. Semaglutide API Certificate of Analysis. Technical documentation. 2022.
10. Polypeptide Group. Stability data for lyophilized GLP-1 receptor agonists. Internal technical report. 2021.
11. FDA. CFR Title 21 Part 211.166: Stability testing for drug products. Code of Federal Regulations. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.